Prostacyclin biosynthesis in vascular endothelium is not inhibited by cyclic AMP. Studies with 3-isobutyl-1-methylxanthine and forskolin
- 1 December 1982
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 28 (5) , 637-647
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prostacyclin and beta-adrenergic catecholamines inhibit arachidonate release and PGI2 synthesis by vascular endotheliumBlood, 1981
- Role of the vascular endotheliumPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1981
- Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin.Journal of Clinical Investigation, 1981
- Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence.Journal of Clinical Investigation, 1979
- Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endotheliumThrombosis Research, 1979
- Stimulation of Endothelial Cell Prostacyclin Production by Thrombin, Trypsin, and the Ionophore A 23187Journal of Clinical Investigation, 1978
- Effect of Aspirin on Thrombin-Induced Adherence of Platelets to Cultured Cells from the Blood Vessel WallJournal of Clinical Investigation, 1978
- Antibodies which antagonise the effects of prostacyclinNature, 1978
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977